Identification of new natural DNA G-quadruplex binders selected by a structure-based virtual screening approach

Molecules

Volumn 18, Issue 10, 2013, Pages 12051-12070

  Artese, Anna ^a   Costa, Giosuè ^a   Ortuso, Francesco ^a   Parrotta, Lucia ^a   Alcaro, Stefano ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

DNA; Docking; G quadruplex; Natural compounds; PDB; Pharmacophore; Virtual screening

Indexed keywords

ACRIDINE DERIVATIVE; BRACO19; CHALCONE DERIVATIVE; DNA; GUANINE QUADRUPLEX; MOLECULAR LIBRARY;

ARTICLE; CHEMISTRY; HUMAN; HYDROGEN BOND; MOLECULAR DOCKING; MOLECULAR LIBRARY; RECEIVER OPERATING CHARACTERISTIC;

ACRIDINES; CHALCONES; DNA; G-QUADRUPLEXES; HUMANS; HYDROGEN BONDING; MOLECULAR DOCKING SIMULATION; ROC CURVE; SMALL MOLECULE LIBRARIES;

EID: 84886615422     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules181012051     Document Type: Article

References (98)

1. Blackburn, E.H.; Gall, J.G. A tandemly repeated sequence at the termini of extrachromosomal ribosomal RNA genes in Tetrahymena. J. Mol. Biol. 1978, 120, 33-53.
2. Allshire, R.C.; Dempster, M.; Hastie, N.D. Human Telomeres contain at least 3 types of G-rich repeat distributed non-randomly. Nucleic Acids Res. 1989, 17, 4611-4627.
3. De Lange, T.; Shiue, L.; Myers, R.M.; Cox, D.R.; Naylor, S.L.; Killery, A.M.; Varmus, H.E. Structure and variability of human chromosome ends. Mol. Cell Biol. 1990, 10, 518-527.
4. Moyzis, R.K.; Buckingham, J.M.; Cram, L.S.; Dani, M.; Deaven, L.L.; Jones, M.D.; Meyne, J.; Ratliff, R.L.; Wu, J.R. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl Acad. Sci. USA 1988, 85, 6622-6626.
5. Wieland, M.; Hartig, J.S. RNA quadruplex-based modulation of gene expression. Chem. Biol. 2007, 14, 757-763.
6. Mullen, M.A.; Olson, K.J.; Dallaire, P.; Major, F.; Assmann, S.M.; Bevilacqua, P.C. RNA G-Quadruplexes in the model plant species Arabidopsis thaliana: Prevalence and possible functional roles. Nucleic Acids Res. 2010, 38, 8149-8163.
7. Zahler, A.M.; Williamson, J.R.; Cech, T.R.; Prescott, D.M. Inhibition of telomerase by G-quartet DNA structures. Nature 1991, 350, 718-720.
8. Burge, S.; Parkinson, G.N.; Hazel, P.; Todd, A.K.; Neidle, S. Quadruplex DNA: Sequence, topology and structure. Nucleic Acids Res. 2006, 34, 5402-5415.
9. Hazel, P.; Parkinson, G.N.; Neidle, S. Predictive modelling of topology and loop variations in dimeric DNA quadruplex structures. Nucleic Acids Res. 2006, 34, 2117-2127.
10. Laughlan, G.; Murchie, A.; Norman, D.; Moore, M.; Moody, P.; Lilley, D.; Luisi, B. The high resolution crystal structure of a parallel-stranded guanine tetraplex. Science 1994, 265, 520-524.
11. Phillips, K.; Dauter, Z.; Murchie, A.I.H.; Lilley, D.M.J.; Luisi, B. The crystal structure of a parallel-stranded guanine tetraplex at 0.95 Å resolution. J. Mol. Biol. 1997, 273, 171-182.
12. Hardin, C.C.; Perry, A.G.; White, K. Thermodynamic and kinetic characterization of the dissociation and assembly of quadruplex nucleic acids. Biopolymers 2000, 56, 147-194.
13. Guedin, A.; Gros, J.; Alberti, P.; Mergny, J.L. How long is too long? Effects of loop size on G-quadruplex stability. Nucleic Acids Res. 2010, 38, 7858-7868.
14. Bugaut, A.; Balasubramanian, S. A sequence-independent study of the influence of short loop lengths on the stability and topology of intramolecular DNA G-quadruplexes. Biochemistry 2008, 47, 689-697.
15. Patel, D.J.; Phan, A.T.; Kuryavyi, V. Human telomere, oncogenic promoter and 5′-UTR G-quadruplexes: Diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res. 2007, 35, 7429-7455.
16. Hurley, L.H.; Wheelhouse, R.T.; Sun, D.; Kerwin, S.M.; Salazar, M.; Fedoroff, O.Y.; Han, F.X.; Han, H.; Izbicka, E.; Von Hoff, D.D. G-quadruplexes as targets for drug design. Pharmacol. Ther. 2000, 85, 141-158.
17. Neidle, S.; Parkinson, G. Telomere maintenance as a target for anticancer drug discovery. Nat. Rev. Drug Discov. 2002, 1, 383-393.
18. De Cian, A.; Lacroix, L.; Douarre, C.; Temime-Smaali, N.; Trentesaux, C.; Riou, J.F.; Mergny, J.L. Targeting telomeres and telomerase. Biochimie 2008, 90, 131-155.
19. Punchihewa, C.; Yang, D.Z. Therapeutic Targets and Drugs: G-Quadruplex and G-Quadruplex Inhibitors. In Cancer Drug Discovery and Development: Telomeres and Telomerase in Cancer; Hiyama, K., Ed.; Humana Press: Totowa, NJ, USA, 2009; pp. 251-280.
20. Gordon, K.E.; Parkinson, E.K. Analysis of telomerase activity and telomere function in cancer. Methods Mol. Biol. 2004, 281, 333-348.
21. Guyen, B.; Schultes, C.M.; Hazel, P.; Mann, J.; Neidle, S. Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase. Org. Biomol. Chem. 2004, 2, 981-988.
22. Shay, J.W.; Gazdar, A.F. Telomerase in the early detection of cancer. J. Clin. Pathol. 1997, 50, 106-109.
23. Harley, C.B. Telomerase and cancer therapeutics. Nat. Rev. Cancer 2008, 8, 167-179.
24. Shay, J.W.; Keith, W.N. Targeting telomerase for cancer therapeutics. Br. J. Cancer 2008, 98, 677-683.
25. Yang, D.; Okamoto, K. Structural insights into G-quadruplexes: Towards new anticancer drugs. Future Med. Chem. 2010, 2, 619-646.
26. Sun, D.; Thompson, B.; Cathers, B.E.; Salazar, M.; Kerwin, S.M.; Trent, J.O.; Jenkins, T.C.; Neidle, S.; Hurley, L.H. Inhibition of human telomerase by a G-quadruplex-interactive compound. J. Med. Chem. 1997, 40, 2113-2116.
27. Monchaud, D.; Teulade-Fichou, M.P. A hitchhiker's guide to G-quadruplex ligands. Org. Biomol. Chem. 2008, 6, 627-636.
28. Fedoroff, O.Y.; Salazar, M.; Han, H.; Chemeris, V.V.; Kerwin, S.M.; Hurley, L.H. NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry 1998, 37, 12367-12374.
29. Haider, S.M.; Parkinson, G.N.; Neidle, S. Structure of a G-quadruplex-ligand complex. J. Mol. Biol. 2003, 326, 117-125.
30. Gavathiotis, E.; Heald, R.A.; Stevens, M.F.; Searle, M.S. Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat. J. Mol. Biol. 2003, 334, 25-36.
31. Campbell, N.H.; Parkinson, G.N.; Reszka, A.P.; Neidle, S. Structural basis of DNA quadruplex recognition by an acridine drug. J. Am. Chem. Soc. 2008, 130, 6722-6724.
32. Parkinson, G.N.; Cuenca, F.; Neidle, S. Topology conservation and loop flexibility in quadruplex-drug recognition: Crystal structures of inter- and intramolecular telomeric DNA quadruplex-drug complexes. J. Mol. Biol. 2008, 381, 1145-1156.
33. Campbell, N.H.; Patel, M.; Tofa, A.B.; Ghosh, R.; Parkinson, G.N.; Neidle, S. Selectivity in ligand recognition of G-quadruplex loops. Biochemistry 2009, 48, 1675-1680.
34. Burger, A.M.; Dai, F.; Schultes, C.M.; Reszka, A.P.; Moore, M.J.; Double, J.A.; Neidle, S. The G-quadruplex interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Res. 2005, 65, 1489-1496.
35. Tauchi, T.; Shin-Ya, K.; Sashida, G.; Sumi, M.; Nakajima, A.; Shimamoto, T.; Ohyashiki, J.H.; Ohyashiki, K. Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: Involvement of ATM-dependent DNA damage response pathways. Oncogene 2003, 22, 5338-5347.
36. Salvati, E.; Leonetti, C.; Rizzo, A.; Scarsella, M.; Mottolese, M.; Galati, R.; Sperduti, I.; Stevens, M.F.; D'Incalci, M.; Blasco, M.; et al. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J. Clin. Invest. 2007, 117, 3236-3247.
37. Tauchi, T.; Shin-ya, K.; Sashida, G.; Sumi, M.; Okabe, S.; Ohyashiki, J.H.; Ohyashiki, K. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: In vitro and in vivo studies in acute leukemia. Oncogene 2006, 25, 5719-5725.
38. Drygin, D.; Siddiqui-Jain, A.; O'Brien, S.; Schwaebe, M.; Lin, A.; Bliesath, J.; Ho, C.B.; Proffitt, C.; Trent, K.; Whitten, J.P.; et al. Anticancer activity of CX-3543: A direct inhibitor of rRNA biogenesis. Cancer Res. 2009, 69, 7653-7661.
39. Read, M.; Cuesta, J.; Basra, I.; Harrison, J.; Reszka, A.; Gowan, S.; Kelland, L.R.; Neidle, S. Rational design approaches to increase the potency of G-quadruplex mediated telomerase inhibitors. Clin. Cancer Res. 2001, 7, 3797S.
40. Read, M.; Harrison, R.J.; Romagnoli, B.; Tanious, F.A.; Gowan, S.H.; Reszka, A.P.; Wilson, W.D.; Kelland, L.R.; Neidle, S. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors. Proc. Natl. Acad. Sci. USA 2001, 98, 4844-4849.
41. Incles, C.M.; Schultes, C.M.; Kempski, H.; Koehler, H.; Kelland, L.R.; Neidle S. A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. Mol. Cancer Therap. 2004, 3, 1201-1206.
42. Kelland, L.R. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics - current status and future prospects. Eur. J. Cancer 2005, 41, 971-979.
43. Gowan, S.M.; Harrison, J.R.; Patterson, L.; Valenti, M.; Read, M.A.; Neidle, S.; Kelland, L.R. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. Mol. Pharmacol. 2002, 61, 1154-1162.
44. Perry, P.J.; Read, M.A.; Davies, R.T.; Gowan, S.M.; Reszka, A.P.; Wood, A.A.; Kelland, L.R.; Neidle, S. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. J. Med. Chem. 1999, 42, 2679-2684.
45. Moorhouse, A.D.; Santos, A.M.; Gunaratnam, M.; Moore, M.; Neidle, S.; Moses, J.E. Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. J. Am. Chem. Soc. 2006, 128, 15972-15973.
46. Huang, H.S.; Chen, I.B.; Huang, K.F.; Lu, W.C.; Shieh, F.Y.; Huang, Y.Y.; Huang, F.C.; Lin, J.J. Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones. Chem. Pharm. Bull. 2007, 55, 284-292.
47. Ma, D.L.; Lai, T.S.; Chan, F.Y.; Chung, W.H.; Abagyan, R.; Leung, Y.C.; Wong, K.Y. Discovery of a Drug-Like G-Quadruplex Binding Ligand by High-Throughput Docking. Chem Med Chem 2008, 3, 881-884.
48. Lee, H.M.; Chan, D.S.H.; Yang, F.; Lam, H.Y.; Yan, S.C.; Che, C.M.; Ma, D.L.; Leung, C.H. Identification of natural product Fonsecin B as a stabilizing ligand of c-myc G-quadruplex DNA by high-throughput virtual screening. Chem. Commun. 2010, 46, 4680-4682.
49. Alcaro, S.; Artese, A.; Costa, G.; Distinto, S.; Ortuso, F.; Parrotta L. Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders. Biochimie 2011, 93, 1267-1274.
50. Artese, A.; Costa, G.; Distinto, S.; Moraca, F.; Ortuso, F.; Parrotta, L.; Alcaro, S. Toward the design of new DNA G-quadruplex ligands through rational analysis of polymorphism and binding data. Eur. J. Med. Chem. 2013, 68, 139-149.
51. Artese, A.; Parrotta, L.; Alcaro, S.; Ortuso, F.; Costa, G.; Sissi, C. Molecular recognition of human telomeric DNA by phenanthroline-based G-quadruplex ligands. Open J. Med. Chem. 2013, 3, 41-49.
52. Alcaro, S.; Artese, A.; Iley, J.N.; Maccari, R.; Missailidis, S.; Ortuso, F.; Ottanà, R.; Ragazzon, P.; Vigorita, M.G. Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffold. Bioorg. Med. Chem. Lett. 2007, 17, 2509-2514.
53. Alcaro, S.; Artese, A.; Iley, J.N.; Missailidis, S.; Ortuso, F.; Parrotta, L.; Pasceri, R.; Paduano, F.; Sissi, C.; Trapasso, F.; et al. Rational design, synthesis, biophysical and antiproliferative evaluation of fluorenone derivatives with DNA G-quadruplex binding properties. Chem. Med. Chem. 2010, 5, 575-583.
54. Doria, F.; Nadai, M.; Folini, M.; di Antonio, M.; Germani, L.; Percivalle, C.; Sissi, C.; Zaffaroni, N.; Alcaro, S.; Artese, A.; et al. Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structures. Org. Biomol. Chem. 2012, 10, 2798-2806.
55. Alcaro, S.; Costa, G.; Distinto, S.; Moraca, F.; Ortuso, F.; Parrotta, L.; Artese, A. The polymorphisms of DNA G-quadruplex investigated by docking experiments with telomestatin enantiomers. Curr. Pharm Des. 2012, 18, 1873-1879.
56. Alcaro, S.; Musetti, C.; Distinto, S.; Casatti, M.; Zagotto, G.; Artese, A.; Parrotta, L.; Moraca, F.; Costa, G.; Ortuso, F.; et al. Identification and characterization of new DNA G-quadruplex binders selected by a combination of ligand and structure-based virtual screening approaches. J. Med. Chem. 2013, 56, 843-855.
57. Truchon, J.F.; Bayly, C.I. Evaluating virtual screening methods: Good and bad metrics for the "early recognition" problem. J. Chem. Inf. Model. 2007, 47, 488-508.
58. Triballeau, N.; Acher, F.; Brabet, I.; Pin, J.P.; Bertrand, H.O. Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J. Med. Chem. 2005, 48, 2534-2547.
59. The Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB). Available online: http://www.rcsb.org/pdb (accessed on 18 September 2013).
60. Wolber, G.; Langer, T. Ligand Scout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J. Chem. Inf. Model. 2005, 45, 160-169.
61. Collie, G.W.; Promontorio, R.; Hampel, S.M.; Micco, M.; Neidle, S.; Parkinson, G.N. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands. J. Am. Chem. Soc. 2012, 134, 2723-2731.
62. Nicoludis, J.M.; Miller, S.T.; Jeffrey, P.D.; Barrett, S.P.; Rablen, P.R.; Lawton, T.J.; Yatsunyk, L.A. Optimized end-stacking provides specificity of n-methyl mesoporphyrin IX for human telomeric G-quadruplex DNA. J. Am. Chem. Soc. 2012, 134, 20446-20456.
63. Friesner, R.A.; Banks, J.L.; Murphy, R.B.; Halgren, T.A.; Klicic, J.J.; Mainz, D.T.; Repasky, M.P.; Knoll, E.H.; Shaw, D.E.; Shelley, M.; et al. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 2004, 47, 1739-1749.
64. Duan, J.; Dixon, S.L.; Lowrie, J.F.; Sherman, W. Analysis and comparison of 2D fingerprint: Insights into database screening performance using eight fingerprint methods. J. Mol. Graph. Model. 2010, 29, 157-170.
65. McCormick, J.L.; McKee, T.C.; Cardellina, J.H.; Boyd, M.R. HIV inhibitory natural products. 26. Quinoline alkaloids from Euodia roxburghiana. J. Nat. Prod. 1996, 59, 469-471.
66. Bai, L.P.; Ho, H.M.; Ma, D.L.; Yang, H.; Fu, W.C.; Jiang, Z.H. Aminoglycosylation can enhance the G-quadruplex binding activity of epigallocatechin. PLoS One 2013, 8, e53962.
67. Alves, D.S.; Perez-Fons, L.; Estepa, A.; Micol, V. Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin. Biochem. Pharmacol. 2004, 68, 549-561.
68. Perry, P.J.; Reszka, A.P.; Wood, A.A.; Read, M.A.; Gowan, S.M.; Dosanjh, H.S.; Trent, J.O.; Jenkins, T.C.; Kelland, L.R.; Neidle, S. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones. J. Med. Chem. 1998, 41, 4873-4884.
69. Moore, M.J.; Schultes, C.M.; Cuesta, J.; Cuenca, F.; Gunaratnam, M.; Tanious, F.A.; Wilson, W.D.; Neidle, S. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. J. Med. Chem. 2006, 49, 582-599.
70. Neidle, S.; Thurston, D.E. Chemical approaches to the discovery and development of cancer therapies. Nat. Rev. Cancer 2005, 5, 285-296.
71. Herraiz, T.; Galisteo, J. Tetrahydro-beta-carboline alkaloids occur in fruits and fruit juices. Activity as antioxidants and radical scavengers. J. Agric. Food Chem. 2003, 51, 7156-7161.
72. Moura, D.J.; Richter, M.F.; Boeira, J.M.; Pêgas Henriques, J.A.; Saffi, J. Antioxidant properties of beta-carboline alkaloids are related to their antimutagenic and antigenotoxic activities. Mutagenesis 2007, 22, 293-302.
73. Wang, F.X.; Deng, A.J.; Li, M.; Wei, J.F.; Qin, H.L.; Wang, A.P. (3S)-1,2,3,4-Tetrahydro-β- carboline-3-carboxylic acid from Cichorium endivia. L induces apoptosis of human colorectal cancer HCT-8 cells. Molecules 2012, 18, 418-429.
74. Wan, Y.Y.; Du, Y.M.; Yang, F.X.; Xu, Y.; Chen, R.Z.; Kennedy, J.F. Purification and characterization of hydrosoluble components from the sap of Chinese lacquer tree Rhus vernici fera. Int. J. Biol. Macromol. 2006, 38, 232-240.
75. Moon, D.O.; Kim, M.O.; Lee, J.D.; Choi, Y.H.; Kim, G.Y. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells. Cancer Lett. 2009, 286, 172-179.
76. Sasaki, S.; Ehara, T.; Sakata, I.; Fujino, Y.; Harada, N.; Kimura, J.; Nakamura, H.; Maeda, M. Development of novel telomerase inhibitors based on a bisindole unit. Bioorg. Med. Chem. Lett. 2001, 11, 583-585.
77. Gaulton, A.; Bellis, L.J.; Bento, A.P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; Al-Lazikani, B.; et al. ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012, 40, D1100-D1107.
78. Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Model. 1988, 28, 31-36.
79. Weininger, D.; Weininger, A.; Weininger, J. L. SMILES. 2. Algorithm for generation of unique SMILES notation. J. Chem. Inf. Model. 1989, 29, 97-101.
80. Kirchmair, J.; Markt, P.; Distinto, S.; Wolber, G.; Langer, T. Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection-What can we learn from earlier mistakes? J. Comput. Aided Mol. Des. 2008, 22, 213-228.
81. Irwin, J.J.; Shoichet, B.K. ZINC-A free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 2005, 45, 177-182.
82. Halgren, T.A. MMFF VI. MMFF94s option for energy minimization studies. J. Comput. Chem. 1999, 20, 720-729.
83. Still, W.C.; Tempczyk, A.; Hawley, R.C.; Hen-drickson, T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J. Am. Chem. Soc. 1990, 112, 6127-6129.
84. Ambinter Natural Products. Available online: http://www.ambinter.com (accessed on July 2013).
85. Analyti Con Discovery NP. Available online: http://www.ac-discovery.com (accessed on 18 September 2013).
86. IBScreen NP. Available online: http://www.ibscreen.com (accessed on 18 September 2013).
87. Indofine Natural Products. Available online: http://www.indofinechemical. com (accessed on 18 September 2013).
88. Molecular Diversity Preservation International. Available online: http://www.mdpi.org (accessed on 18 September 2013).
89. Nubbe Natural Products. Available online: http://nubbe.iq.unesp.br (accessed on 18 September 2013).
90. Princeton NP. Available online: http://www.princetonbio.com (accessed on 18 September 2013).
91. Selleck BioChemicals NP. Available online: http://www.selleckbio.com (accessed on 18 September 2013).
92. Specs Natural Products. Available online: http://www.specs.net (accessed on 18 September 2013).
93. TCM Database@Taiwan. Available online: http://tcm.cmu.edu.tw (accessed on 18 September 2013).
94. UEFS Natural Products. Available online: http://www.uefs.br (accessed on 18 September 2013).
95. Chem Axon. Available online: http://www.chemaxon.com (accessed on 18 September 2013).
96. Hawkins, P.C.D.; Skillman, A.G.; Warren, G.L.; Ellingson, B.A.; Stahl, M.T. Conformer generation with OMEGA: Algorithm and validation using high quality structures from the Protein Data Bank and Cambridge Structural Database. J. Chem. Inf. Model. 2010, 50, 572-584.
97. Hawkins, P.C.D.; Nicholls, A. Conformer generation with OMEGA: Learning from the data set and the analysis of failures. J. Chem. Inf. Model. 2012, 52, 2919-2936.
98. Maestro Graphics User Interface, version 9.4; Schrödinger, LLC, New York, NY, USA, 2013.